From: Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 rats
Affymetrix | |||||||
---|---|---|---|---|---|---|---|
Accession no. | Gene ID | Significance | Pooled | Individual | Taqman | Custom-made | FACS |
Upregulated | |||||||
X56596 | MHC class I antigen RT1.B-1 β-chain (MhcII) | S | I (47.4) | I (43.4); P < 0.0001 | ND | I (2.8); P < 0.1 | I (1.9); P < 0.03 |
U24441 | Metalloproteinase 9 (Mmp9) | T | I (5) | I (1.5); P < 0.001 | I (1.9); P < 0.08 | NC‡ | ND |
S81478 | CL100 protein tyrosine phosphatase (Ptpn16) | T | I (2.4) | NC* | ND | I (1.6); P < 0.02 | ND |
Downregulated | |||||||
L07399 | (Hybridoma 56R-7) immunoglobulin rearranged γ-chain variable (Ig γ) | S | D (-6.4) | NC* | ND | D (-2.0); P < 0.02 | ND |
L07401 | (Hybridoma 57R-1) immunoglobulin rearranged γ-chain variable (Ig γ) | S | D (-62.4) | NC* | D (-2.1); P < 0.03 | NC‡ | ND |
M14434 | Immunoglobulin active κ-chain VJC region from immunocytoma IR2 (Ig κ) | S | D (-34.7) | NC* | ND | D (-1.9); P < 0.003 | ND |
X00923 | IgE heavy chain (Ig ε) | S | D (-28) | NC* | ND | D (-2.0); P < 0.05 | ND |
S81289 | IgM κ-chain variable (Ig κ) | S | D (-9.3) | NC* | ND | D (-2.5); P < 0.0003 | ND |
M15402 | Immunoglobulin active κ-chain VJ region from immunocytoma IR162 (Ig κ) | S | D (-3.9) | NC* | ND | D (-3.0); P < 0.006 | ND |
nm_013121 | CD28 (Cd28) | S | NC | NC* | ND | D (-2.2); P < 0.01 | D (-9.8); P < 0.03 |
S69206 | Mast cell protease 1 (Mcpt1) | S | D (-4.7) | NC* | ND | D (-2.1); P < 0.002 | ND |
AB010635 | Carboxylesterase precursor (Ces2) | S | D (-4.1) | NC* | ND | D (-2.5) ; P < 0.003 | ND |
D25290 | K-cadherin (Cdh6) | S | D (-4.1) | NC* | ND | D (-1.7) ; P < 0.01 | ND |
X70871 | Cyclin G1 (Ccng1) | S | D (-9.6) | D (-4.8); P < 0.001 | D † | NC‡ | ND |
AJ011608 | DNA polymerase α-subunit IV (Primase) | S | D (-3.3) | D (-2.6); P < 0.001 | D (-3.5); P < 0.03 | NC‡ | ND |
L12025 | Tumour-associated glycoprotein E4 (Tage) | T | D (-3.1) | NC* | ND | D (-1.8); P < 0.1 | ND |